Bid Publish Date
09-Oct-2026, 2:41 pm
Bid End Date
19-Oct-2026, 3:00 pm
Value
₹15,439
Location
Progress
Organization: Employees State Insurance Corporation (ESIC) – procurement of pharmaceutical items including Acetazolamide Tablets (V2) (Q2), Clindamycin Injection (Q2), Amitriptyline Tablets (V2) (Q2), Baclofen Tablets (V2) (Q2), and Heparin Injection (Q2). Estimated Value: ₹15,439.00. No explicit location provided; tender appears under ESIC pharmaceutical category with multiple drug items listed. Quantity flexibility up to ±25% of bid quantity during contract, and additional delivery time calculated as (additional quantity/original quantity) × original delivery period, minimum 30 days. The option clause may extend delivery at contracted rates. This ATC clause demands bidder compliance and readiness for quantity variation and extended delivery scenarios.
Item list includes Acetazolamide Tablets (V2) (Q2), Clindamycin Injection (Q2), Amitriptyline Tablets (V2) (Q2), Baclofen Tablets (V2) (Q2), Heparin Injection (Q2)
Estimated value: ₹15,439.00
Delivery quantity variance: ±25% of bid quantity
Delivery period calculation: (additional quantity ÷ original quantity) × original delivery period, minimum 30 days
BOQ indicates Total Items: 0; no itemized quantities available in data
No explicit technical performance standards provided in data; bidders should anticipate standard pharma procurement norms and quality compliance
Quantity may be increased/decreased by up to 25% at contract placement or during currency at contracted rates
Delivery period may extend based on option clause with minimum 30 days added time
No BOQ item quantities published; bidders must confirm exact drug quantities and delivery timelines before bid submission
Brief description of payment conditions
Brief description of delivery requirements
Brief description of penalty clauses if any
Adequate pharmaceutical supply capability for acetazolamide, clindamycin, amitriptyline, baclofen, and heparin
Experience in government or ESIC procurement preferred
Compliance with GST, PAN, and standard financial requirements
Quantity
14270
Category
Acetazolamide Tablets (V2)
Bid Type
Two Packet Bid
Bid Validity
180 (Days)
Bid Type
Service
Evaluation
Item wise evaluation
Inspection Required
No
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Tech Clarification Time
2 Days
EMD Required
No
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
No
Bid Splitting Applied
No
OEM Avg. Turnover
1
Past Performance
80 %
Experience Required
3 Year (s)
Arbitration Clause
No
Mediation Clause
No
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Acetazolamide Tablets (V2) (Q2) , Clindamycin Injection (Q2) , Amitriptyline Tablets (V2) (Q2) , Baclofen Tablets (V2) (Q2) , Heparin Injection (Q2)
Pre-Bid Date
14-10-2026 12:00:00
Pre-Bid Venue
On Online Mode Google meet ID :https://meet.google.com/pse-wyzg-upv
Max Delivery Days
45
Delivery Locations
1
Delivery Cities
Ernakulam
Delivery Pincodes
683501
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| Madhu P R | 683501,ESIC HOSPITAL, PATHALAM JUNCTION, UDYOGAMANDAL P.O., ERNAKULAM | Ernakulam | Kerala | 683501 | 100 | 45 | - |
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Discover companies most likely to bid on this tender
GST registration certificate
Permanent Account Number (PAN) card
Experience certificates for similar pharmaceutical supply
Financial statements or turnover proof
Manufacturer Authorization or OEM authorization (if applicable)
Technical bid documents and compliance certificates
Any applicable quality certifications for acetazolamide, clindamycin, amitriptyline, baclofen, and heparin
EMD submission documents (if required by ESIC terms)
Bidders should prepare GST registration, PAN, experience certificates, and financials, plus OEM authorizations if required. Ensure compliance with ESIC ATC terms, submit technical and financial bids, and be ready to meet quantity variation up to 25% and delivery within extended timelines per clause.
Submit GST certificate, PAN card, company/organization credentials, experience certificates for similar pharmaceutical supply, financial statements, EMD (if applicable), OEM authorizations, and technical compliance certificates. Ensure all documents reflect items: acetazolamide, clindamycin, amitriptyline, baclofen, and heparin.
Delivery can be adjusted by up to ±25% of bid quantity. The delivery period starts from the last date of the original order, with potential extension calculated as (additional quantity/original quantity) × original delivery period, minimum 30 days.
The tender covers Acetazolamide Tablets (V2) (Q2), Clindamycin Injection (Q2), Amitriptyline Tablets (V2) (Q2), Baclofen Tablets (V2) (Q2), and Heparin Injection (Q2).
The tender shows an estimated value of ₹15,439.00 with unclear EMD amount in the data; bidders should verify EMD requirements and ensure bid validity within ESIC terms.
If the item requires OEM authorization, provide manufacturer authorization letters for each API or finished drug if applicable, along with product-specific certificates verifying composition, potency, and regulatory compliance.
Tender data does not specify exact standards; bidders should anticipate ISI/BIS, GMP, DCGI approvals, and ISO quality management certifications as applicable to pharmaceutical supply and ESIC procurement norms.
The tender data does not specify a fixed deadline; bidders should obtain the ATC document and confirm delivery milestones in the final contract and during bid submission.